Evidence map›Paper›PMID 39917570›Full record

ArticleInternational medical case reports journal2025

Omadacycline for the Treatment of Severe

Limin Xu, Ying Xiong, Changquan Fang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Limin XuDepartment of Geriatrics, Huizhou First Hospital, Huizhou, Guangdong Province, Peoples' Republic of China.
Ying XiongDepartment of Pulmonary and Critical Care Medicine, Huizhou Central People's Hospital, Huizhou, Guangdong Province, Peoples' Republic of China.
Changquan FangDepartment of Pulmonary and Critical Care Medicine, Huizhou Central People's Hospital, Huizhou, Guangdong Province, Peoples' Republic of China.ORCID 0000-0002-4971-1407

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fluoroquinolones and macrolides are the preferred antibiotics for treating Legionnaires' disease. However, the limited utility of these antibiotics in cases of organ dysfunction is a major problem. Omadacycline is a novel tetracycline antibiotic with a good safety profile and in vitro antibacterial activity against Case Description: Here, we report a case of severe pneumonia caused by Conclusion:

Indexed as

antibiotic therapyLegionella pneumoniaLegionnaires‘diseasemetagenomic next-generation sequencingomadacycline

Identifiers

PMID39917570
PMCPMC11799771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.